Literature DB >> 22626930

Evasion from NK cell-mediated immune responses by HIV-1.

Stephanie Jost1, Marcus Altfeld.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) mostly owes its success to its ability to evade host immune responses. Understanding viral immune escape mechanisms is a prerequisite to improve future HIV-1 vaccine design. This review focuses on the strategies that HIV-1 has evolved to evade recognition by natural killer (NK) cells.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22626930      PMCID： PMC3432664          DOI： 10.1016/j.micinf.2012.05.001

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  120 in total

1.  Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity.

Authors:  Cristina Cerboni; Francesca Neri; Nicoletta Casartelli; Alessandra Zingoni; David Cosman; Paolo Rossi; Angela Santoni; Margherita Doria
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

2.  Specific and nonspecific NK cell activation during virus infection.

Authors:  A O Dokun; S Kim; H R Smith; H S Kang; D T Chu; W M Yokoyama
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

Review 3.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

4.  CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

Authors:  Chiara Romagnani; Kerstin Juelke; Michela Falco; Barbara Morandi; Antonella D'Agostino; Roberta Costa; Giovanni Ratto; Giuseppe Forte; Paolo Carrega; Gabrielle Lui; Romana Conte; Till Strowig; Alessandro Moretta; Christian Münz; Andreas Thiel; Lorenzo Moretta; Guido Ferlazzo
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

Review 5.  Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules.

Authors:  J C Boyington; A G Brooks; P D Sun
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

6.  Recognition of viral hemagglutinins by NKp44 but not by NKp30.

Authors:  T I Arnon; M Lev; G Katz; Y Chernobrov; A Porgador; O Mandelboim
Journal:  Eur J Immunol       Date:  2001-09       Impact factor: 5.532

7.  Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Authors:  Veit Hornung; Simon Rothenfusser; Stefanie Britsch; Anne Krug; Bernd Jahrsdörfer; Thomas Giese; Stefan Endres; Gunther Hartmann
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

8.  Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule.

Authors:  José M Lozano; Rafael González; José M Kindelán; Nathalie Rouas-Freiss; Rafael Caballos; Jean Dausset; Edgardo D Carosella; José Peña
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

9.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

10.  Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.

Authors:  Hathairat Thananchai; Geraldine Gillespie; Maureen P Martin; Arman Bashirova; Nobuyo Yawata; Makoto Yawata; Philippa Easterbrook; Daniel W McVicar; Katsumi Maenaka; Peter Parham; Mary Carrington; Tao Dong; Sarah Rowland-Jones
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422
View more
  28 in total

1.  CD4+ T cell-dependent and CD4+ T cell-independent cytokine-chemokine network changes in the immune responses of HIV-infected individuals.

Authors:  Kelly B Arnold; Gregory L Szeto; Galit Alter; Darrell J Irvine; Douglas A Lauffenburger
Journal:  Sci Signal       Date:  2015-10-20       Impact factor: 8.192

2.  Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque.

Authors:  Mauricio A Martins; Damien C Tully; Young C Shin; Lucas Gonzalez-Nieto; Kim L Weisgrau; David J Bean; Rujuta Gadgil; Martin J Gutman; Aline Domingues; Helen S Maxwell; Diogo M Magnani; Michael Ricciardi; Nuria Pedreño-Lopez; Varian Bailey; Michael A Cruz; Noemia S Lima; Myrna C Bonaldo; John D Altman; Eva Rakasz; Saverio Capuano; Keith A Reimann; Michael Piatak; Jeffrey D Lifson; Ronald C Desrosiers; Todd M Allen; David I Watkins
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-29       Impact factor: 2.205

Review 3.  Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?

Authors:  A Saez-Cirion; B Jacquelin; F Barré-Sinoussi; M Müller-Trutwin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

Review 4.  Adaptive NK cell responses in HIV/SIV infections: A roadmap to cell-based therapeutics?

Authors:  Daniel R Ram; Cordelia Manickam; Olivier Lucar; Spandan V Shah; R Keith Reeves
Journal:  J Leukoc Biol       Date:  2019-02-07       Impact factor: 4.962

5.  MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape.

Authors:  Phillip Pymm; Patricia T Illing; Sri H Ramarathinam; Geraldine M O'Connor; Victoria A Hughes; Corinne Hitchen; David A Price; Bosco K Ho; Daniel W McVicar; Andrew G Brooks; Anthony W Purcell; Jamie Rossjohn; Julian P Vivian
Journal:  Nat Struct Mol Biol       Date:  2017-02-20       Impact factor: 15.369

Review 6.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

7.  The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors:  Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

8.  HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?

Authors:  Juan C Hernandez; Georges St Laurent; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

Review 9.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

10.  Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.

Authors:  Xuan He; Camille R Simoneau; Mitchell E Granoff; Sebastian Lunemann; Anne-Sophie Dugast; Yiming Shao; Marcus Altfeld; Christian Körner
Journal:  J Immunol Methods       Date:  2016-04-16       Impact factor: 2.303
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.